Research on depression and its treatment. Covers stress-response biology, ketamine and dopamine-targeting therapies, treatment-resistant cases, and brain mechanisms.
A new study confirms that electroconvulsive therapy (ECT) is associated with improved health-related quality of life in the short term and long term. ECT, a treatment for severe mental illness, was found to improve symptoms of depression and enhance overall well-being in patients who attained remission.
A new study suggests that persistent fatigue is a better indicator of postpartum depression than stress or family history. Women who experienced prolonged fatigue were more likely to develop symptoms of postpartum depression, highlighting the importance of early screening and intervention.
A new study by Florida State University researchers suggests that depression is a lifelong parent trap. The study found that no type of parent reports less depression than non-parents, and certain types of parenting have higher levels of depression. Parents living with minor children tend to have the least symptoms of depression.
A study found that Alzheimer's patients with a history of depression have more rapid cognitive decline and greater brain changes, including tangles and plaques in the hippocampus. The findings suggest that identifying potential mechanisms linking geriatric depression to AD may lead to new treatment strategies.
A study found that patients with depression had more tangles and plaques in the hippocampus, leading to a faster decline into dementia. Depression at diagnosis also predicted a greater rate of cognitive decline.
A study published in JAMA found that pregnant women with major depression are at a high risk of relapse if they discontinue antidepressant medication. The research highlights the need for accurate information and treatment guidelines to help clinicians make informed decisions about managing depression during pregnancy.
Recent developments in depression treatment highlight the effectiveness of antidepressants and electroconvulsive therapy (ECT) as mainstay treatments. ECT is particularly recommended for patients presenting with psychotic symptoms, while antidepressants remain a primary choice for most patients due to their widespread availability and ...
Researchers found that childhood sexual abuse, poor parent-child relationships, and low social support were common risk factors for depression in both men and women. However, the study revealed that childhood parental loss and low self-esteem were more potent variables in men than in women.
Researchers found that the protein p11 helps regulate serotonin signaling, which is a key target of antidepressants. Increasing p11 levels can lead to improved mood and reduced depression-like symptoms in mice.
A VCU study found that the heritability of major depression is approximately 42% in women and 29% in men, indicating a potential sex-specific genetic component. The research team analyzed data from over 42,000 twins to understand the role of genetics in depression.
Researchers have identified a gene called p11 as being involved in the complex changes underlying depression. Decreased levels of p11 protein are found in both human patients with depression and mouse models of the disease. The study suggests that increasing p11 levels could be a new target for developing anti-depressant compounds.
Research suggests that people in middle-income areas are more likely to respond to depression treatment than those in low-income areas. The study found an inverse relationship between median household income and suicidality, with low-income areas having a higher risk of suicidal behavior.
A third of patients with major depressive disorder (MDD) fully recovered from symptoms after initial treatment with antidepressant medication. Nearly 47% showed a response rate, with one in three achieving symptom-free state.
About a third of participants reached remission or virtual absence of symptoms, while nearly two thirds remained treatment-resistant. The study, STAR*D, included 2,876 participants and was conducted over six years.
Researchers in antidepressant studies focus on symptoms to gauge remission, while patients prioritize factors like positive mental health and return to usual functioning. Studies suggest that patients consider multiple factors beyond symptom disappearance to determine remission from depression.
A study by Wake Forest University found that Latino men experiencing family-related ambivalence during migration are more likely to suffer from anxiety. The researchers suggest enhancing communication between migrants and their families could help address mental health needs.
A sociological study found that parenthood is not associated with improved mental health, contrary to cultural beliefs. Parents with minor stepchildren and single parents report more symptoms of depression than childless individuals. Married parents residing with their own minor children actually experience less depression.
A 6-week group intervention using cognitive-behavioral techniques reduced depressive symptoms in low-income single mothers, while a study illustrates the effectiveness of cost-effective nursing interventions for improving mental health outcomes.
A study found that etanercept reduced psoriasis severity by 47% and improved depression symptoms by 50% in patients with moderate to severe psoriasis. The treatment also alleviated fatigue, showing promise for treating the emotional and psychological effects of the disease.
A study published in Neurology found that depression and anxiety disorders decreased by over 50% two years after epilepsy surgery. Participants who underwent successful surgery without seizures were more likely to be free from depression and anxiety.
Patients with bipolar disorder experience worsening psychosocial disability as depressive symptom severity increases, and vice versa. Psychosocial functioning normalizes when patients are asymptomatic, but remains poor compared to well controls.
A team care model, including a case manager and primary care provider, results in better outcomes for treating clinical depression. The IMPACT program provides powerful health benefits, including decreased depression and pain, improved physical functioning, and better overall quality of life.
A recent study examined the impact of the 1988 Spitak earthquake on adolescents in Armenia and found that psychotherapy provided sustained benefits even 1.5 years post-disaster. Untreated adolescents had higher levels of PTSD and depressive symptoms, while treated adolescents saw significant improvements in their conditions.
Chronic major depressive episodes are associated with older age, lower education and income, medical illnesses, and lack of private insurance. African Americans and patients in primary care settings experience more chronicity.
A randomized controlled trial has validated a brief version of the Hamilton Depression Scale (HAMD-7) for measuring depression severity in primary care settings. The findings suggest that this shorter scale is accurate and can be used by physicians in clinical practice.
Researchers found that people with mildly depressed symptoms are more perceptive of their social environment than those without. They can identify subtle cues, such as eye expressions, to gauge others' emotions and mental states.
Researchers found a twofold increase in adolescent depression visits between 1995 and 2002, with medication use rising from 47% to 52% and psychotherapy dropping from 83% to 68%. SSRIs accounted for 76% of prescribed antidepressants during this period.
Researchers at Ohio State University found that hamsters exposed to limited daylight before birth exhibited increased depressive symptoms as adults. The study suggests a link between seasonal light exposure, sex, and depression in hamsters, providing potential insight into human seasonal affective disorder.
A study by Johns Hopkins Medicine reveals that mental illnesses like depression and anxiety cause workers to work fewer hours, take more disability time, and be less productive. Employers can combat these costs by providing quality psychiatric evaluations and treatment plans.
Research by Marshfield Clinic found that vacations decrease depression and tension odds among women who take them more frequently. The study also found that taking fewer vacations is linked to lower marital satisfaction.
Researchers found widespread claims that SSRIs restore serotonin balance, despite lack of scientific support. Consumer ads for SSRIs often claim to correct a chemical imbalance, but this is not supported by scientific evidence.
A new approach to preventing SAD by starting antidepressant treatment in the fall has shown promise. Early intervention with bupropion-XL reduced the risk of fall-winter depression by 44% in patients with a history of recurring episodes.
A study assessing anxiety, depression, and quality of life in Greek patients with cancer undergoing chemotherapy found that nearly a third experienced severe emotional distress. Routine screening for emotional distress is recommended to identify patients in need of psychological or pharmaceutical intervention. Additionally, research on...
A study published by the University of Vermont suggests that cognitive-behavioral therapy (CBT) is a more effective long-term treatment for SAD than light therapy. The study found that patients who received CBT showed comparable improvement to those who received light therapy, but with better long-term benefits.
Patients with diabetes and depression are more likely to have cardiovascular and cerebrovascular complications, as well as increased mortality rates. The study found that a sedentary lifestyle was an important independent predictor of mortality from diabetes.
A recent study found that nearly one in five depressed African-American participants developed a disability within two years of enrolling, compared to one in twenty non-depressed peers. Chronic conditions and functional limitations also played a significant role in the excess disability incidence related to depression.
A new study finds black women with chronic pain experience higher levels of disability, post-traumatic stress disorder, and emotional impairment compared to white women. The research emphasizes the need for improved access to quality pain care and a better understanding of minority patients' needs.
A large-scale study found that women experiencing burnout have elevated levels of fibrinogen and C-reactive protein (CRP), associated with increased cardiovascular disease risk. Men experiencing depression also showed higher levels of CRP and fibrinogen, linking emotional states to inflammation-related health problems
The National Institute of Mental Health expands its public health education effort to address the lack of awareness about depression among Latino men. The new campaign, Real Men Real Depression, aims to teach Latino men that depression is a medical condition affecting both mind and body.
A study found a surprising link between depression, suicide, and epilepsy, with people with epilepsy being 4 times more likely to have attempted suicide before having a seizure. Depression was also found to increase the risk of developing epilepsy.
A double-blind, placebo-controlled trial found that chromium picolinate supplementation significantly reduced carbohydrate cravings and improved symptoms of atypical depression. The study suggests that chromium picolinate may be beneficial for patients with severe carbohydrate craving, a characteristic symptom of the disorder.
A large cohort study found a significant association between panic disorder and an increased risk of coronary heart disease. The study, which analyzed data from nearly 40,000 patients, suggests that cardiologists and internists should monitor patients with panic disorder to reduce the risk of cardiovascular disease.
A study by Newcastle University found that men who experience a downward social shift are four times more likely to suffer depression, whereas women in the same position show no significant difference. The researchers suggest that this disparity may be due to differences in how men and women derive self-esteem and fulfillment.
Researchers are exploring novel mechanisms for antidepressant drug action, hoping to develop better treatments for depression. The study aims to identify compounds that facilitate neurogenesis, increasing the potential for innovative therapies.
A study of 32 patients with heart failure found that those experiencing depression had nearly twice the levels of tumor necrosis factor alpha (TNF-alpha) in their blood. This increase was associated with worsened heart function, as TNF-alpha promotes inflammation and reduces the heart's ability to pump blood effectively.
A new study found that telephone-administered cognitive-behavioral therapy (T-CBT) significantly improved depression symptoms in patients with multiple sclerosis. The treatment was more effective than supportive emotion-focused therapy (T-SEFT) and showed lasting gains.
VNS therapy has been shown to be effective for some patients with treatment-resistant depression, with up to 20% experiencing total remission. The treatment involves surgical implantation of a device that stimulates the vagus nerve, delivering mild pulses to areas of the brain involved in mood regulation.
The NewMood project aims to identify genetic traits that contribute to depression by analyzing brain responses to fearful faces and rewards. Volunteers will participate in a online test and provide a mouth swab for genetic analysis.
A new project in Australia is exploring the economic benefits of treating depression in employees. The WORC Project has surveyed 80,000 employees and found that treating depression can recoup $338 per employee per year, improving morale and reducing costs associated with absenteeism and work under-productivity.
A 15-year longitudinal study found that individuals diagnosed with minor depression were more likely to develop major depression, particularly among young adults (18-29 years old) and women. The study also revealed that cancer and other chronic illnesses did not increase the risk of developing major depression.
A four-year multicenter study will examine why minorities face dangerous misdiagnoses for mood disorders, leading to excessive antipsychotic drug use among African-Americans. The research aims to identify underlying reasons and develop new education techniques to improve diagnosis and treatment plans.
A new clinical trial at UT Southwestern Medical Center has shown that cognitive therapy can effectively treat recurrent depression in patients. The study, which involves 16-20 sessions of cognitive therapy over 12 weeks, has been shown to improve treatment outcomes for individuals with major depressive disorder (MDD).
A 25-year study found high rates of PTSD and major depression among US Cambodian refugees who experienced trauma before and after immigration. The study highlights the need for additional mental health resources to address the community's substantial unmet needs.
A study of Cambodian immigrants in the US found a significant prevalence of PTSD and depression, with rates highest among older, poorer, and unemployed individuals. The research suggests that these disorders may be linked to a single continuum of posttraumatic stress.
A new study found that cognitive therapy significantly reduced repeat suicide attempts among participants, with a 50% decrease in such attempts. The therapy was effective in reducing depressive symptoms and improving coping mechanisms.
Researchers at Harvard Medical School have identified a novel function for the molecule Par-4 as a binding partner for dopamine receptor D2. This discovery suggests that Par-4 may play a crucial role in regulating depression-like behaviors, providing a potential new target for antidepressants.
A study of 5,364 patients found that knee pain is often accompanied by pain in other joints, leading to poorer general and psychological health. The results suggest that managing pain in one region can have beneficial effects on overall perception of pain.
A study of depressed heart patients found that those with low heart rate variability were nearly three times more likely to die after a heart attack. Researchers hope that treating depression and correcting heart rate variability may offer improved survival rates for these patients.
Researchers found that transcranial magnetic stimulation (TMS) is as effective as electro-shock therapy in alleviating severe depression. However, TMS has fewer side effects, particularly memory impairment. Patients treated with TMS showed significant improvement in mood without affecting the hippocampus.
A study found that antidepressants reduced the risk of death and non-fatal heart attacks by 43% in depressed heart attack patients. The analysis was based on data from the Enhancing Recovery in Coronary Heart Disease clinical trial, which randomized 2,481 patients with depression or social isolation between 1996 and 1999.